Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000246

Drug Information
NameTerbutaline
SynonymsSpectrum_001030; Spectrum2_001327; Spectrum5_001262; Terbutalinum; Prestwick3_000391; KWD-2019; Spectrum4_000870; 1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-; DivK1c_000078; Oprea1_823972; 5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL; BRN 2370513; Terbutaline (INN); EINECS 245-385-8; BSPBio_000601; KBio2_001510; Prestwick2_000391; 23031-25-6; KBio1_000078; 5-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}benzene-1,3-diol; Terbutalinum [INN-Latin]; Brethaire; Brican; terbutaline; Lopac0_001126; 1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-; Bricaril; (+-)-5-(2-((1,1-Dimethylethyl)amino)-1-hydroxyethyl)-1,3-benzenediol; Benzyl alcohol, .alpha.-((t-butylamino)methyl)-3,5-dihydroxy-; SPBio_002522; Prestwick1_000391; SBB063955; DB00871; SPBio_001453; D08570; 46719-29-3; AC1L1KA2; KBioSS_001510; KWD 2019; UNII-N8ONU3L3PG; Asthmasian (TN); 23031-32-5 (Sulfate); Terbutalin; BPBio1_000663; Spectrum3_000593; Terbutaline sulfate; I01-3464; IDI1_000078; PDSP2_000157; CHEMBL1760; NCGC00089821-02; L000594; Prestwick0_000391; KBio2_004078; AB00053548; KBioGR_001539; LS-29961; (+-)-Terbutaline; Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy-; BSPBio_002066; Brethine; Bricanyl; 1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-, (+-)-; NCGC00016010-06; Terbutalino [INN-Spanish]; PDSP1_000158; NINDS_000078; Terbutaline [INN:BAN]; KBio3_001566; 1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9CI); BRD-A50157456-065-02-4; KBio2_006646; Bricyn; Asthmasian; Terbutalina; Bricar; Terbutalino; C07129; Terbutalina [DCIT]; MolPort-003-850-418; CID5403; LS-7713; 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol
Trade NameBrethine; Bricanyl; Brethaire
CompanyBen Venue Laboratories, Inc
IndicationAsthma
[ICD9: 493   ICD10: J45]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13
-16H,7H2,1-3H3
InChIKeyXWTYSIMOBUGWOL-UHFFFAOYSA-N
Canonical SMILESCC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 23031-25-6
FormulaC12H19NO3
PubChem Compound IDCID 5403.
PubChem Substance IDSID 9339.
SuperDrug ATC IDR03AC03; R03CC03
SuperDrug CAS ID023031256;
TargetBeta-2 adrenergic receptorAgonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 075877 To Reference
Ref 2Evaluation of a new oral beta2-adrenoceptor stimulant bronchodilator, terbutaline. Pharmacology. 1975;13(3):201-11. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543